Frequency of ``optimal anticoagulation'' for acute myocardial infarction after thrombolysis with front-load recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023) - Zeymer,U.; von Essen,R.; Tebbe,U. (Am J Cardiol, 1995)